Price to Sales ratio Analysis of Spero Therapeutics Inc - Deep Dive


Latest FY PS
Period Ending - Dec-23

0.988


Very Good PS
Period Ending - Dec-22
0.997

Very Good PS
Growth
-0.991 %
Trailing Twelve Months PS
Period Ending - Dec-23

171.29


Very Poor PS
PS Analysis of Spero Therapeutics Inc
P/S Ratio of Spero Therapeutics Inc with value of 171.29 indicates that stock price is high compared to sales of the company and may be overvalued.
PS Ratio of SPRO has fallen by -0.991 % Compared to previous Financial Year.
PS Ratio with value of 3.41 was highest in Year Dec-20 in last Five Years.
PS Ratio of SPRO trending down for at least three Years.
Latest PS Ratio with value of 0.988 is lower than Average PS of 1.84 in last five years.
Other PS Related Info of SPRO that may interest you.
Spero Therapeutics Inc Overview
CodePricePrevious PricePrice ChangeSector
SPRO1.421.42 0 % Biotechnology
Fundamental AnalysisTechnical Analysis
Defination of Price to Sales
The Price to Sales Ratio indicates how much investors are willing to pay for each rupee of sales generated by a company. Price-to-Sales Ratio is used to determine whether a stock is currently profitable or less profitable, which is helpful for better investment decisions.   more ..
Price to Sales Formula

PS Related Ratios
PriceToBookRatioPriceToEarningRatioAssetTurnoverRatio

Tsr Value Index
Very Low Value Stock
FY - Historical Price to Sales of Spero Therapeutics Inc
PeriodDec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17
PS0.9880.9972.403.411.425.731.86
Change-0.991 %-58.50 %-29.47 %139.76 %-75.20 %208.67 %-82.12 %
You are view first 7 Records. Log in to view all 9 in Premium view
FY Chart of Price to Sales of Spero Therapeutics Inc


Note : All Data Generated at the End of Trading Hours (EOD Data)